• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Diagnostic value of monocyte chemoattractant protein-1 (MCP-1) and lactate dehydrogenase (LDH) in malignant pleural effusion: A cross-sectional study.

作者信息

Muhammad Iqbal, Putra Ngakan P P, Setyawan Ungky A, Setijowati Nanik

机构信息

Department of Pulmonology and Respiratory Medicine, Medical Faculty of Universitas Brawijaya - Saiful Anwar General Hospital, Malang City, East Java, Indonesia.

Department of Family Medicine, Medical Faculty of Universitas Brawijaya, Malang City, East Java, Indonesia

出版信息

Lung India. 2025 Jan 1;42(1):66-67. doi: 10.4103/lungindia.lungindia_239_24. Epub 2024 Dec 24.

DOI:10.4103/lungindia.lungindia_239_24
PMID:39718923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11789956/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3e/11789956/a45259bce903/LI-42-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3e/11789956/a45259bce903/LI-42-66-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a3e/11789956/a45259bce903/LI-42-66-g001.jpg

相似文献

1
Diagnostic value of monocyte chemoattractant protein-1 (MCP-1) and lactate dehydrogenase (LDH) in malignant pleural effusion: A cross-sectional study.单核细胞趋化蛋白-1（MCP-1）和乳酸脱氢酶（LDH）在恶性胸腔积液中的诊断价值：一项横断面研究。
Lung India. 2025 Jan 1;42(1):66-67. doi: 10.4103/lungindia.lungindia_239_24. Epub 2024 Dec 24.
2
A potential target for the future treatment of malignant pleural effusion: Monocyte chemoattractant protein-1 (MCP-1).恶性胸腔积液未来治疗的一个潜在靶点：单核细胞趋化蛋白-1（MCP-1）。
Cancer Biomark. 2025 Jan;42(1):18758592241293231. doi: 10.1177/18758592241293231. Epub 2025 Mar 20.
3
Diagnostic accuracy of pleural fluid lactate dehydrogenase to adenosine deaminase ratio for tuberculous pleural effusion: an analysis of two cohorts.胸腔积液乳酸脱氢酶与腺苷脱氨酶比值对结核性胸腔积液的诊断准确性：两项队列分析。
BMC Pulm Med. 2022 Nov 19;22(1):428. doi: 10.1186/s12890-022-02247-w.
4
Diagnostic utility of measuring lactate dehydrogenase levels and its isoenzyme activities for the evaluation of malignancy in feline pleural effusion and ascitic fluid.用于评估猫胸腔积液和腹水恶性肿瘤的乳酸脱氢酶水平及其同工酶活性的诊断效用。
Open Vet J. 2022 Sep-Oct;12(5):735-743. doi: 10.5455/OVJ.2022.v12.i5.19. Epub 2022 Oct 5.
5
Diagnostic utility of LDH, CA125 and CYFRA21-1 in tuberculosis pleural effusion.LDH、CA125 和 CYFRA21-1 对结核性胸腔积液的诊断价值。
Med Clin (Barc). 2022 Jan 21;158(2):70-72. doi: 10.1016/j.medcli.2020.10.017. Epub 2021 Jan 23.
6
The role of pleural fluid lactate dehydrogenase-to-adenosine deaminase ratio in differentiating the etiology of pleural effusions.胸腔积液乳酸脱氢酶-腺苷脱氨酶比值在鉴别胸腔积液病因中的作用。
Chin J Physiol. 2022 May-Jun;65(3):105-108. doi: 10.4103/cjp.cjp_104_21.
7
Diagnostic value of lactate dehydrogenase isoenzyme pattern in pleural effusions.乳酸脱氢酶同工酶谱在胸腔积液中的诊断价值。
Eur J Clin Chem Clin Biochem. 1997 Jul;35(7):523-8. doi: 10.1515/cclm.1997.35.7.523.
8
Diagnostic value of ferritin, haptoglobin, alpha 1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation.铁蛋白、触珠蛋白、α1-抗胰蛋白酶、乳酸脱氢酶及补体因子C3和C4在胸腔积液鉴别诊断中的价值
Respir Med. 1997 Oct;91(9):517-23. doi: 10.1016/s0954-6111(97)90084-6.
9
Identifying Malignant Pleural Effusion by A Cancer Ratio (Serum LDH: Pleural Fluid ADA Ratio).通过癌症比率（血清乳酸脱氢酶：胸水腺苷脱氨酶比率）识别恶性胸腔积液。
Lung. 2016 Feb;194(1):147-53. doi: 10.1007/s00408-015-9831-6. Epub 2015 Dec 17.
10
Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-β, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion.胸腔积液中血管内皮生长因子、转化生长因子-β、白细胞介素-8 和乳酸脱氢酶与腺苷脱氨酶比值的诊断价值。
Lung. 2018 Apr;196(2):249-254. doi: 10.1007/s00408-018-0090-1. Epub 2018 Jan 20.

本文引用的文献

1
Predicting Survival for Patients with Malignant Pleural Effusion: Development of the CONCH Prognostic Model.预测恶性胸腔积液患者的生存率：CONCH预后模型的开发。
Cancer Manag Res. 2021 Jun 14;13:4699-4707. doi: 10.2147/CMAR.S305223. eCollection 2021.
2
Malignant Pleural Effusion: From Diagnostics to Therapeutics.恶性胸腔积液：从诊断到治疗。
Clin Chest Med. 2018 Mar;39(1):181-193. doi: 10.1016/j.ccm.2017.11.004. Epub 2017 Dec 13.
3
Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion.
胸膜乳酸脱氢酶作为伴有恶性胸腔积液的肺腺癌的预后标志物。
Medicine (Baltimore). 2016 Jun;95(26):e3996. doi: 10.1097/MD.0000000000003996.
4
Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma.在原发性肺腺癌患者中，单核细胞趋化蛋白-1、肿瘤坏死因子-α和白细胞介素-6 在恶性胸腔积液的控制和生存中的作用。
Int J Biol Markers. 2012 Jul 19;27(2):e118-24. doi: 10.5301/JBM.2012.9197.